← Back to headlines
Amylyx Pharmaceuticals Completes Avexitide Phase 3 Lucidity Trial Enrollment
Amylyx Pharmaceuticals (AMLX) has successfully completed the enrollment for its Avexitide Phase 3 Lucidity Trial.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Bataan Freeport Residents Assured Housing Privileges Amid ID Issue
just now
Philippines urged to crack down on 'unreasonable' fuel price hikes
just now
DSWD Completes Cash Aid Distribution for Tricycle Drivers in Western Visayas
just now